Ivan Ross Vrána is the VP for Government Relations and Business Development for Eve & Co. He dropped by the studio to discuss his background at Health Canada, his work at H&K Strategies and his new role at Eve & Co.
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step...
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to...
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step...
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to...
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis...
Ananda Pharma, one of the UK's leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping...
The afternoon sessions at Tuesday's inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential,...
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in...
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal....
Cookies, the most globally recognised cannabis brand, is entering global medical markets with a full extract portfolio through a strategic...
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well...
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
